Dr. Mark J. Kulbaski, MD

Dr. Kulbaski practices at Vascular Care Specialists in Brockton, Massachusetts.

Dr. Kulbaski's NPI, 1699756247, was assigned on November 10, 2005. Dr. Kulbaski graduated from University of Pittsburgh School of Medicine in 1990. Dr. Kulbaski holds Massachusetts license 78343.

Dr. Kulbaski's primary practice is Vascular Care Specialists, at 830 Oak St, Brockton, MA 02301 in Plymouth County. The practice phone is (774) 480-1600.

Dr. Kulbaski's primary practice is Vascular Care Specialists in Brockton, Massachusetts. Dr. Kulbaski is also affiliated with Signature Healthcare Brockton Hospital. The medical group on file is Steward Medical Group. Dmand AI also links Dr. Kulbaski to 2 more hospitals, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kulbaski practices, 5 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Kulbaski's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dr. Kulbaski is board certified in vascular surgery by the American Board of Surgery. Dmand AI has Dr. Kulbaski's licenses on file in 4 states: Massachusetts, New York, Pennsylvania and Georgia.

Dmand AI lists aortic atherosclerois, arterial blot clot /embolism, carotid revascularization, chronic skin ulcer, deep vein thrombosis (DVT), heart device and aorta surgery, leg revascularization and peripheral vascular disease among the conditions Dr. Kulbaski treats.

CMS data shows 4,337 Medicare services from Dr. Kulbaski across 24 procedure codes in 2024, for 795 Medicare patients. Medicare paid $220,850 for them.

CMS counts 795 Medicare patients who saw Dr. Kulbaski in 2024. The largest group is 75 to 84, with 375 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 24% are also on Medicaid. Their average risk score is 2.01, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kulbaski's median patient age at 73, with 43% women.

In 2024, Dr. Kulbaski wrote 446 Medicare Part D claims for 124 patients. 93% of them were for generic drugs. CMS names the drug for 360 of them, across 4 drugs with 11 or more claims each, at $16,069 in total drug cost. In 2023, CMS named 211 claims across 3 drugs.

Dr. Kulbaski accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 14 procedures of leg revascularization (restoring blood flow) by Dr. Kulbaski, more than 70% of the clinicians it reports for that procedure.

Varicose vein removal: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 9 papers to Dr. Kulbaski. The most frequent topics are Endoscopy, Ischemia and Leg. Dr. Kulbaski's most frequent co-authors are Alan B. Lumsden, MD, William T. Brinkman, MD and Ruth L. Bush, MD.

CMS Open Payments shows 99 general payments to Dr. Kulbaski from 29 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 60% of the total. Philips Electronics North America Corporation paid the most, $2,181.

Dmand AI lists 1 award for Dr. Kulbaski.

Dr. Kulbaski graduated from University of Pittsburgh School of Medicine in 1990. Dr. Kulbaski is a member of ACS.

Dr. Kulbaski is in network with 12 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.